Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending September 27, 2020

Review finds evidence for beta-blockers for some rosacea symptoms,

DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use,

No prior use of insulin predicts postsurgical diabetes remission,

Nationwide study questions routine long-term beta-blocker post MI,

Vascular dementia risk particularly high in type 2 diabetes,

More must reads

Must reads for theWeek ending September 20, 2020

Late-onset neutropenia more common than expected in patients on rituximab,

Study validates OSA phenotypes in Latinos,

Insomnia may have a role in generation of stressful life events,

AI algorithm on par with radiologists as mammogram reader,

Biologics for psoriasis may also reduce coronary plaque,

More must reads

Must reads for theWeek ending September 13, 2020

Increasing hepatitis C treatment may curb hepatocellular carcinoma,

Social distancing impacts other infectious diseases,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,

High disability after a year of RA treatment signals increased mortality risk,

Insomnia + COPD linked to more outpatient, ED visits,

More must reads

Must reads for theWeek ending August 30, 2020

EMPEROR-Reduced: Empagliflozin's HFrEF benefit solidifies class effects,

Early rhythm control in AFib gains new life,

SARS-CoV-2 appears unlikely to pass through breast milk,

Mortality burden of dementia may be greater than estimated,

Researchers home in on optimal biopsy length for giant cell arteritis,

More must reads

Must reads for theWeek ending August 30, 2020

EMPEROR-Reduced: Empagliflozin's HFrEF benefit solidifies class effects,

Early rhythm control in AFib gains new life,

SARS-CoV-2 appears unlikely to pass through breast milk,

Mortality burden of dementia may be greater than estimated,

Researchers home in on optimal biopsy length for giant cell arteritis,

More must reads

Pages